Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Healthcare Biotechnology
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


GREY:FRTX - Post by User

Fresh Tracks Therapeutics Inc
Bullboard Posts
User Avatar Image
(329)
•••
Post by plantraderon Aug 09, 2018 9:03am
209 Views
Post# 28432325

Stage vs Gryphon? Challenging the Infringement Claim?

Stage vs Gryphon? Challenging the Infringement Claim?I'm obviously not an attorney; most posts are open questions. Just showing what I've found online.

https://www.patexia.com/lawsuits/Stage-Completions-Inc-v-Campbell-et-al-id-112143

https://portal.unifiedpatents.com/ptab/case/IPR2018-00776

https://s3-us-west-1.amazonaws.com/ptab-filings%2FIPR2018-00776%2F11


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities